Saturday 17 October 2026
Export FMS’s income statement to Excel — free account
Fresenius Medical Care AG & Co. KGaA
FMS Healthcare Medical Care Facilities
Fresenius Medical Care AG & Co. KGaA’s revenue for fiscal 2025 (year ended December 2025) was $22.2 billion, up 6.13% from fiscal 2024. In the quarter to June 2026, revenue grew 3.89%, EPS grew 6.82%, free cash flow grew 1.57% and total debt rose 5.57%, each against the same quarter a year earlier. Dividend growth for three consecutive years.
22.17
0.04
+0.18%
Follow FMS
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
20.96 | 22.27 | 8.46 | 16.67 | 18.47 | 16.56 | 13.43 | 23.10 | 22.87 | 12.47 |
Piotroski F-Score |
7 | 7 | 7 | 4 | 7 | 5 | 5 | 5 | 7 | 8 |
P/S ratio |
1.45 | 1.60 | 1.02 | 1.14 | 1.20 | 0.91 | 0.46 | 0.59 | 0.64 | 0.62 |
Altman Z-Score |
2.55 | 2.83 | 2.31 | 1.77 | 1.96 | 1.63 | 1.43 | 1.60 | 1.68 | 1.88 |
Altman Z″-Score (non-manufacturers) |
3.06 | 2.78 | 3.29 | 2.14 | 2.44 | 2.24 | 2.38 | 2.64 | 2.75 | 2.93 |
P/FCF ratio |
22.96 | 21.02 | 15.88 | 13.69 | 6.69 | 9.69 | 6.06 | 5.88 | 7.22 | 6.88 |
Beneish M-Score |
(2.52) | (2.62) | (2.33) | (2.61) | (2.98) | (2.47) | (2.69) | (2.69) | (2.71) | (2.77) |
P/Operating CF |
30.69 | 61.48 | 19.54 | 25.41 | 42.89 | 23.81 | 13.41 | 16.27 | 15.22 | 12.96 |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 42 |
P/B ratio |
2.26 | 2.62 | 1.30 | 1.51 | 1.74 | 1.15 | 0.58 | 0.78 | 0.78 | 0.86 |
Price to Tangible BV |
0.00 | 0.00 | 1,526.35 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
1.88 | 1.96 | 1.34 | 1.60 | 1.58 | 1.31 | 0.84 | 0.91 | 0.88 | 0.89 |
EV/EBITDA |
9.88 | 11.25 | 5.90 | 7.24 | 6.90 | 6.66 | 4.84 | 5.70 | 5.41 | 5.27 |
EV/Operating CF |
15.76 | 15.91 | 10.77 | 10.90 | 6.66 | 9.30 | 7.49 | 6.76 | 7.10 | 6.54 |
EV/FCF |
29.90 | 25.81 | 20.97 | 19.25 | 8.82 | 13.96 | 10.97 | 9.07 | 9.97 | 9.83 |
Quick Ratio |
0.89 | 0.83 | 0.89 | 0.65 | 0.70 | 0.70 | 0.77 | 0.86 | 0.89 | 0.84 |
Current Ratio |
1.45 | 1.20 | 1.25 | 1.02 | 1.18 | 1.10 | 1.27 | 1.42 | 1.40 | 1.26 |
Net Debt/EBITDA |
2.29 | 2.09 | 1.44 | 2.09 | 1.66 | 2.04 | 2.17 | 2.00 | 1.49 | 1.58 |
Debt/Assets |
31.82% | 31.00% | 28.76% | 27.56% | 24.89% | 24.94% | 23.87% | 23.30% | 18.73% | 23.56% |
Debt/Equity |
0.75 | 0.69 | 0.58 | 0.69 | 0.64 | 0.61 | 0.55 | 0.53 | 0.40 | 0.51 |
Asset Turnover |
0.68 | 0.74 | 0.67 | 0.58 | 0.56 | 0.54 | 0.52 | 0.57 | 0.57 | 0.62 |
Operating CF/Net income |
1.72 | 1.71 | 1.04 | 2.14 | 3.64 | 2.57 | 3.22 | 5.27 | 4.44 | 2.74 |
Capex/Depreciation |
(1.30) | (1.14) | (1.38) | (0.70) | (0.58) | (0.51) | (0.37) | (0.38) | (0.39) | (0.60) |
Interest Coverage |
5.83 | 5.95 | 6.77 | 4.62 | 5.62 | 5.24 | 4.20 | 3.22 | 3.42 | 4.75 |
| 11.33% | 12.21% | 17.04% | 8.94% | 9.20% | 7.49% | 4.32% | 3.34% | 3.52% | 6.66% | |
| 4.75% | 5.35% | 8.05% | 3.96% | 3.64% | 2.98% | 1.81% | 1.45% | 1.59% | 3.10% | |
ROIC |
8.55% | 8.54% | 10.37% | 6.66% | 7.53% | 5.49% | 4.16% | 4.06% | 4.26% | 5.84% |
Return on Tangible Assets |
20.55% | 28.03% | 36.60% | 27.59% | 22.51% | 19.60% | 11.44% | 7.83% | 9.10% | 19.04% |
Average Days of Receivables |
76.32 | 70.66 | 75.67 | 74.78 | 66.31 | 73.99 | 69.89 | 68.23 | 64.33 | 59.04 |
Research and Development Expense of Revenue |
0.91% | 0.73% | 0.81% | 0.96% | 1.09% | 1.25% | 1.18% | 1.19% | 0.95% | 0.80% |
Selling, General and Administrative Expense of Revenue |
17.00% | 20.12% | 17.32% | 17.51% | 17.72% | 17.57% | 19.51% | 16.43% | 16.25% | 15.45% |
Intangible Assets out of Total Assets |
0.54 | 0.53 | 0.49 | 0.47 | 0.45 | 0.46 | 0.48 | 0.47 | 0.49 | 0.48 |
Share Based Compensation of Revenue |
0.17% | 0.26% | 0.06% | 0.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
(0.32) | (0.24) | (0.33) | (0.63) | (0.56) | (0.77) | (1.35) | (0.90) | (0.80) | (0.72) |
Graham Number |
29.18 | 32.49 | 46.28 | 34.88 | 34.82 | 35.28 | 27.37 | 23.79 | 25.45 | 34.53 |
Earnings Yield |
4.77% | 4.49% | 11.82% | 6.00% | 5.41% | 6.04% | 7.45% | 4.33% | 4.37% | 8.02% |
Free Cash Flow Yield |
4.36% | 4.76% | 6.30% | 7.30% | 14.94% | 10.32% | 16.50% | 17.01% | 13.85% | 14.54% |
Revenue per Share |
29.29 | 32.78 | 31.87 | 32.33 | 34.69 | 35.58 | 34.85 | 35.88 | 35.66 | 38.13 |
Operating CF per Share |
3.50 | 4.04 | 3.97 | 4.75 | 8.22 | 5.03 | 3.89 | 4.85 | 4.40 | 5.21 |
Capex per Share |
(1.66) | (1.55) | (1.93) | (2.06) | (2.01) | (1.68) | (1.24) | (1.23) | (1.26) | (1.75) |
Free Cash Flow per Share |
1.84 | 2.49 | 2.04 | 2.69 | 6.21 | 3.35 | 2.66 | 3.62 | 3.14 | 3.46 |
Cash per Share |
1.22 | 1.80 | 4.13 | 1.86 | 2.10 | 2.99 | 2.29 | 3.04 | 2.98 | 3.97 |
Shareholders Equity per Share |
18.74 | 19.96 | 24.85 | 24.47 | 23.95 | 28.23 | 27.75 | 27.35 | 29.08 | 27.75 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
18.74 | 19.96 | 24.85 | 24.47 | 23.95 | 28.23 | 27.75 | 27.35 | 29.08 | 27.75 |
Free Cash Flow |
1,127.55 | 1,526.56 | 1,250.87 | 1,628.14 | 3,651.65 | 1,963.43 | 1,558.90 | 2,121.68 | 1,840.53 | 2,016.52 |
Working Capital |
2,276.66 | 1,214.41 | 1,864.33 | 176.86 | 1,274.43 | 839.54 | 1,829.20 | 2,802.96 | 2,448.45 | 1,870.54 |
Capital Expenditures |
(1,012.33) | (950.85) | (1,184.24) | (1,246.85) | (1,183.88) | (981.90) | (724.65) | (723.47) | (741.51) | (1,016.76) |
Net Current Asset Value |
(8,162.92) | (7,711.62) | (6,487.74) | (14,047.44) | (13,801.74) | (14,694.44) | (12,750.12) | (11,257.93) | (10,686.09) | (9,980.22) |
EV/EBIT |
12.78 | 14.76 | 7.31 | 12.33 | 12.24 | 12.51 | 10.73 | 12.98 | 12.17 | 9.59 |
Capex to Sales |
0.06 | 0.05 | 0.06 | 0.06 | 0.06 | 0.05 | 0.04 | 0.03 | 0.04 | 0.05 |
Price to Operating Income |
9.82 | 12.02 | 5.54 | 8.77 | 9.29 | 8.68 | 5.93 | 8.41 | 8.82 | 6.71 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.21 | 0.21 | 0.19 | 0.38 | 0.44 | 0.38 | 0.44 | 0.46 | 0.48 | 0.43 |
Cash ROIC |
5.43% | 7.01% | 4.69% | 6.24% | 15.01% | 6.91% | 5.86% | 8.04% | 7.19% | 7.54% |
Accounts Receivable Turnover |
4.94 | 5.26 | 4.92 | 4.86 | 5.29 | 5.26 | 5.02 | 5.36 | 5.49 | 6.10 |
Accounts Payable Turnover |
14.56 | 15.49 | 15.18 | 14.44 | 14.97 | 15.14 | 14.87 | 16.22 | 15.60 | 16.43 |
Inventory Turnover |
8.82 | 9.28 | 8.43 | 7.53 | 6.99 | 6.48 | 6.15 | 6.58 | 6.86 | 7.09 |
Average Days of Payables |
26.63 | 22.86 | 25.47 | 25.23 | 24.51 | 24.96 | 24.13 | 22.24 | 24.64 | 20.89 |
Days of Inventory on Hand |
42.42 | 39.99 | 47.00 | 50.25 | 56.14 | 59.31 | 59.49 | 54.75 | 51.77 | 53.52 |
Average Receivables |
3,624.27 | 3,818.13 | 3,971.24 | 4,030.74 | 3,858.19 | 3,965.76 | 4,069.39 | 3,924.61 | 3,811.82 | 3,640.01 |
Average Payables |
832.95 | 859.52 | 886.47 | 937.18 | 940.27 | 979.84 | 997.90 | 969.63 | 1,011.57 | 1,005.24 |
Average Inventory |
1,375.29 | 1,434.40 | 1,595.63 | 1,797.58 | 2,013.94 | 2,288.09 | 2,415.23 | 2,388.91 | 2,298.11 | 2,329.88 |
Average Assets |
26,149.60 | 27,044.77 | 29,073.86 | 33,939.51 | 36,542.65 | 38,428.73 | 39,164.81 | 37,196.39 | 36,522.31 | 35,699.22 |
Average Common Equity |
10,976.53 | 11,848.08 | 13,738.16 | 15,025.86 | 14,450.29 | 15,312.33 | 16,407.93 | 16,162.01 | 16,554.94 | 16,611.34 |
Columns are period end dates